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Current understanding of tyrosine kinase BMX in 
infl ammation and its inhibitors
Introduction 
The response of  cells to extracellular stimuli is in part medi-
ated by a number of intracellular kinases. Tec family kinases, 
as the second largest group of  non-receptor tyrosine kinases, 
are of  critical importance to the biology of  lymphocytes and 
other cell lineages derived from the bone marrow.[1] Five 
distinct subgroups within the  Tec kinase family have been 
described. These include (1) tyrosine kinase expressed in 
hepatocellular carcinoma (TEC), (2) Bruton’s tyrosine kinase 
(BTK), (3) interleukin (IL)-2-inducible T-cell kinase (ITK), 
(4) tyrosine-protein kinase (TXK), and (5) bone marrow 
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tyrosine kinase on chromosome X (BMX).[2] Tec family 
kinases have been the focus of  immunological interest ever 
since their discovery.
While BTK, ITK and TXK show selective expression in 
cells of  bone marrow origin,[3] the expression patterns 
of  BMX and TEC are broader and extends to certain 
normal somatic cells — such as the cardiac endothe-
lium as a response to ischemia and pressure overload.[4] 
Specifically, BMX is expressed in hematopoietic cells of  
the myeloid lineage like granulocytes and monocytes.[5,6] 
Besides, BMX expression has also been demonstrated in 
glioblastoma cancer stem cells and several solid tumors, 
such as prostate and breast cancer. BMX has been sug-
gested to have a role in differentiation, motility and 
cell survival.[7] The endothelial cells, granulocytes and 
monocytes play critical roles in the inflammation. This 
review will examine BMX biology, its role in inflamma-
tion and possible signaling pathway, and the potential of  
selective BMX inhibitors.
A B S T R A C T
Tec family kinases, which include tyrosine kinase expressed in hepatocellular carcinoma (TEC), Bruton's tyrosine kinase (BTK), 
interleukin (IL)-2-inducible T-cell kinase (ITK), tyrosine-protein kinase (TXK), and bone marrow tyrosine kinase on chromosome X 
(BMX), are the second largest group of non-receptor  tyrosine kinases and have a highly conserved carboxyl-terminal kinase domain. 
BMX was identifi ed in human bone marrow cells, and was demonstrated to have been expressed in myeloid hematopoietic lineages 
cells,  endothelial cells, and several types of cancers. Signifi cant progress in this area during the last decade revealed an important 
role for BMX in infl ammation and oncologic disorders. This review focuses on BMX biology, its role in  infl ammation and possible 
signaling pathways, and the potential of selective BMX inhibitors.
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Structure and function of BMX
Like many other kinase families, members of  the Tec 
kinase have a typical array of  regulatory domains and 
a highly conserved carboxyl-terminal kinase domain 
[Figure 1].[8] As such, BMX has Src homology (SH)3 and 
SH2 domains and a carboxyl-terminal kinase domain.[9] The 
aminoterminus contains a membrane localization module 
that is a characteristic feature of  the TEC kinases and sets 
them apart from other non-receptor tyrosine kinases.[10]
An amino-terminal pleckstrin homology (PH) domain, 
which binds to phosphatidylinositols during the process 
of  membrane localization,[11] is followed by a zinc-binding 
BTK homology (BH) motif  and a proline-rich region, which 
shows a low degree of  conservation to the other family 
members.[7] The SH2, SH3 and BH domains all mediate 
inter- and intramolecular protein interactions that are likely 
to regulate kinase activity and substrate access.[7] 
BMX was the latest identified one among the 5 human TEC 
kinases. In 1994, the human BMX gene was first identified 
and  cloned in bone marrow cells by Tamagnone et al.[12] The 
BMX gene is located in chromosomal band X p22.2 between 
the DXS197 and DXS207 loci.[12] The BTK gene, the closest 
relative of BMX, is also located in chromosome X. The BMX 
gene encodes a protein with 675 amino acids, of which 70% are 
identical with BTK.[12] Mutations in BTK gene are responsible 
for X-linked agammaglobulinemia (XLA) in humans or X-
linked immunodeficiency (XID) in mice.[8] However, diseases-
associated BMX gene mutations have not been described yet. 
BMX in inflammation
Inflammation is a necessary and rapid, yet coordinated 
response that is induced by microbial infection or tissue 
injury.[13] Triggers capable of  inducing an inflammatory 
response include tissue damage and infection by pathogenic 
and nonpathogenic microbes.[13] Undue prolongation of  
inflammation can be very destructive or even initiate the 
systemic inflammatory response syndrome, multiple organ 
failure and death.[14] The inflammatory cytokines, which 
affect various and numerous physiologic activities, play 
a significant role in the pathogenesis of  inflammation. 
In the previous studies, tumor necrosis factor (TNF)-α, 
IL-1β and IL-6 have been demonstrated to be the core 
of  the cytokine-network and play a critical role in the 
inflammatory response.[15,16] During the immune response, 
the cytokine IL-8 functions as a potent neutrophil attractant 
and activator leads to the recruitment of  neutrophils from 
blood, penetration of  these cells through the vessel wall, 
and their directed migration to inflammatory sites and 
contributes to the advance of  inflammation by releasing 
superoxide anion, matrix metalloproteinase, leukotriene 
B(4) and platelet-activating factor.[17-19]
There is emerging evidence that non-receptor tyrosine kinase 
BMX is involved in the pathogenesis of  inflammatory dis-
orders, such as rheumatoid arthritis (RA).[7,20,21] An siRNA 
against BMX-inhibited lipopolysaccharide (LPS)-induced 
IL-6 secretion in synovial fibroblasts.[22] In macrophages 
and synovial fibroblasts from RA patients, overexpression of  
BMX mediates an increase in LPS-induced stabilization of  
the IL-6 mRNA.[20,21] In the absence of  LPS, overexpression 
of  BMX failed to induce IL-6 mRNA expression. Further 
study revealed that transient depletion of  BMX strongly re-
duced secretion of  IL-8 in human fibroblasts stimulated by 





ischemia, BMX is activated and suppressing BMX activity 
protects against neurodegeneration.[23] Altogether, an essen-
tial role for the tyrosine kinase BMX in cytokine signaling 
and inflammation has been established. 
The stimulation of Toll-like receptor (TLR)4 by LPS induces 
the release of  critical pro-inflammatory cytokines that result 
in systemic inflammation and sepsis.[16,24] TLR4 signaling has 
been divided into MyD88-dependent and MyD88-indepen-
dent pathways. Signaling through the MyD88-dependent 
pathway leads to the activation of  p38 mitogen-activated 
protein kinase (MAPK), c-Jun NH(2)-terminal kinase (JNK), 
and nuclear factor-κB (NF-κB).[25,26] Such signaling activa-
tion consequently lead to the release of  pro-inflammatory 
cytokines including TNF-α and IL-1β.[27,28] 
An siRNA against BMX strongly reduces secretion of  IL-8 
in cell lines and HUVECs stimulated by TLR4 agonist, sug-
gesting that BMX could play a role in inflammatory-signal-
ing pathways.[7] Study performed on RA synovial fibroblasts 
demonstrated that BMX is activated by TLR agonists and 
that it functionally and physically interacts with the com-
ponents of  the MyD88-dependent TLR pathway MyD88 
and Mal as shown by co-immunoprecipitation.[22] More 
specifically, BMX was required for phosphorylation of  p38 
MAPK and JNK, as well as activation of  NF-κB.[7,11,29] An 
epistasis analysis indicated that BMX functionally regulates 
the complex transforming growth factor (TGF)-β activated 
kinase (TAK)1-binding protein complex.[7] The possible role 
of  BMX in TLR4 signaling is shown in Figure 2. Studies 
  
Figure 1: Schematic representation of bone marrow tyrosine kinase on 
chromosome X (BMX) structural domains. PH = pleckstrin homology, 
BH = BTK homology, SH = Src homology.
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performed on COS cells and HEK293 cells revealed that 
BMX induced the tyrosine phosphorylation and DNA bind-
ing activity of  all the Stat factors tested, including STAT1, 
STAT3 and STAT5.[30] Further study demonstrated that 
BMX is a critical mediator of  Src-induced cell transforma-
tion and STAT3 activation.[31,32] However, the upstream lo-
calization of  BMX kinase relative to the adaptor molecules 
and the exact mechanism of  BMX-dependent regulation of  
cytokine gene expressions warrants further studies. 
BMX kinase inhibitors
As shown in the previously mentioned data, BMX is an 
important molecule involved in the inflammatory processes. 
Modulating BMX activity might control the excessive 
inflammatory response. Prerequisite for the treatment 
of  inflammation by modifying BMX activity is to use a 
specific, non-toxic inhibitor.[33] 
In order to develop irreversible BMX inhibitors, Liu and 
his colleagues developed compounds capable of  targeting 
cysteine (Cys) 496. Kinome-wide sequence alignment 
reveals that all 5 TEC family kinases have the conserved 
cysteine. Dr. Liu introduced an electrophilic acrylamide 
moiety targeting Cys 496 and first successfully synthe-
sized a selective BMX inhibitor, called BMX-IN-1.[34] 
The chemical structure is shown in Figure 3. In RV-1 
cells, 1 μM of  BMX-IN-1 is sufficient to inhibit BMX 
autophosphorylation.[34] 
Ibrutinib (PCI-32765), a reported irreversible inhibitor of  
BTK, is also a potent inhibitor of  BMX and other TEC 
family kinases.[35,36] Primary data showed that ibrutanib is 
beneficial in models of  arthritis and patients with relapsed 
or refractory chronic lymphocytic leukemia.[36,37] 
Whether these inhibitors could provide significant beneficial 
effects in inflammatory diseases remains to be established.
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Figure 2: Role of bone marrow tyrosine kinase on chromosome X 
(BMX) in Toll-like receptor (TLR)4 signaling. BMX has been reported 
to interact with adaptor molecules (MyD88, or Mal) and transforming 
growth factor (TGF)-β activated kinase (TAK)1, leading to the activation 
of the NF-κB and MAPK-signaling pathways. This process results 
in infl ammatory cytokine production. MD = myeloid differentiation 
protein, TRIF = Toll/interleukin-1 receptor domain-containing adaptor 
protein inducing interferon-β, TRAM = TRIF-related adaptor molecule, 
IRAK = interleukin-1 receptor-associated kinase, TRAF = TNF receptor-
associated factor, MAPK = mitogen-activated protein kinases, IKK 
= inhibitor kappa B kinase, AP = activator protein.
Figure 3: The chemical structure of BMX-IN-1, an irreversible 
BMX inhibitor. [Figure is from Liu F, et al. ACS Chem Biol 
2013;8(7):1423-8.][33]
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